mary j. fidler, md, discusses the significance of the impower010 clinical trial
Published 3 years ago • 37 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
0:59
mary j. fidler, md, provides opinion on the role of nivolumab ipilimumab in the treatment of nsclc
-
0:44
mary j. fidler, md, regarding the role of trilaciclib as a supportive care agent for sclc patients
-
0:38
mary j. fidler, md, on combination lurbinectedin & checkpoint inhibitors in the treatment of sclc
-
0:52
mary jo fidler, md, medical oncologist at rush
-
1:17
dr. mary jo fidler on the role of oligoclonal t cell expansion in nsclc
-
14:35
all about leptomeningeal disease (lmd)
-
5:52
small cell lung cancer (small cell carcinoma) | usmle step 1 mnemonic
-
3:16
good to know - functional mri (fmri)
-
1:34
dr. fidler on the utility of dacomitinib in egfr-mutant nsclc
-
0:46
fda approves capmatinib for advanced lung cancer
-
1:33
dr. anne chiang on molecular testing in lung cancer treatment planning
-
0:42
dr. fidler discusses osimertinib in egfr-mutated lung cancer
-
2:10
proclipi: registry & establishment of a prognostic index for mf and ss
-
24:33
adjuvant therapy: the next step in lung cancer treatment
-
1:00
dr. eleftherios mamounas on predicting the risk of dcis recurrence
-
4:17
fda approves atezolizumab as adjuvant treatment for non-small cell lung cancer
-
23:57
discover remarkable: at the heart of medicine - lung cancer
-
6:02
choices among immunotherapeutics may be the future of lung cancer care
-
7:41
repeat testing at progression of egfr nsclc
-
2:19
5-year dmfs outcomes in the nbreast ii trial
-
4:11
how to get your tumor tested - lung cancer foundation of america (lcfa)
-
5:00
the hipec program at mercy health st mary's